沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

已收盘 03-19 16:08:15

5.940

+0.000

0.00%

最高5.940	最低5.780	成交量102.10万
今开5.830	昨收5.940	日振幅2.69%
总市值39.92亿	流通市值39.92亿	总股本6.72亿
成交额593.86万	换手率0.15%	流通股本6.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":5.94,"timestamp":1773907695006,"preClose":5.94,"halted":0,"volume":1021000,"delay":0,"changeRate":0,"floatShares":672000000,"shares":672000000,"eps":-0.338431,"marketStatus":"已收盘","change":0,"latestTime":"03-19 16:08:15","open":5.83,"high":5.94,"low":5.78,"amount":5938605,"amplitude":0.026936,"askPrice":5.94,"askSize":5000,"bidPrice":5.81,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.372288,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773970200000},"marketStatusCode":5,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":5.94,"openAndCloseTimeList":[[1773883800000,1773892800000],[1773896400000,1773907200000]],"volumeRatio":1.801977,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2620243092","title":"之江生物（688317）披露公司产品获得马来西亚医疗器械管理局认证，3月19日股价下跌2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620243092","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620243092?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:10","pubTimestamp":1773911417,"startTime":"0","endTime":"0","summary":"截至2026年3月19日收盘，之江生物报收于19.47元，较前一交易日下跌2.06%，最新总市值为37.41亿元。近日，上海之江生物科技股份有限公司发布《关于自愿披露公司产品获得相关认证的公告》。公告显示，公司两项产品“Viral RNA Isolation Kit ”和“Viral RNA Extraction Kit”近期获得马来西亚医疗器械管理局认证，认证有效期分别为2026年3月6日至2031年3月5日、2026年2月27日至2031年2月26日，适用范围为临床样本中核酸的提取，可在马来西亚及认可该认证的国家销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900027622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK0239","BK1583","688317","BK1222","BK1574","09996","159883","09997"],"gpt_icon":0},{"id":"2620126252","title":"浩欧博（688656）披露全资子公司获得两项医疗器械注册证，3月18日股价上涨0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620126252","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620126252?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:32","pubTimestamp":1773844336,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘，浩欧博报收于142.03元，较前一交易日上涨0.69%，最新总市值为90.16亿元。该股当日开盘144.0元，最高144.34元，最低137.49元，成交额达5652.8万元，换手率为0.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800040822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK1100","159883","09996","BK1574","BK1222","BK0239","BK1583","09997"],"gpt_icon":0},{"id":"2620565256","title":"博济医药：服务植入式脑深部刺激系统等脑科医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2620565256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620565256?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:51","pubTimestamp":1773838302,"startTime":"0","endTime":"0","summary":"有媒体报道贵公司子公司九泰药械目前有为诸如植入式脑深部刺激系统、磁刺激调控治疗抑郁症等脑神经科学方面的医疗器械提供临床研究服务，消息是否属实。九泰药械持续关注国家政策及行业动向带来的行业机遇，提升竞争优势，并专注于为所在领域企业提供优质的医疗器械临床试验及注册申报服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800038770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","09997","BK1209","LU0329678170.USD","BK1222","159883","LU0329678337.USD","LU2488822045.USD","BK0216","BK1100","300404","BK1583","BK1574","06078","LU0737861772.HKD"],"gpt_icon":0},{"id":"2620518239","title":"微创脑科学(02172)：APOLLO Dream®雷帕霉素靶向洗脱支架系统荣获FDA突破性医疗器械认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2620518239","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620518239?lang=zh_cn&edition=full","pubTime":"2026-03-18 17:20","pubTimestamp":1773825636,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创脑科学 发布公告，集团自主研发的APOLLO Dream雷帕霉素靶向洗脱支架系统近期获得美国食品药品监督管理局授予的突破性医疗器械认定，成为全球首个获得该项认定的神经介入领域球囊扩张、快速交换式药物洗脱支架。APOLLO Dream支架系统专为对现有最佳药物治疗无效的症状性颅内动脉狭窄患者而设计。与传统药物支架相比，APOLLO Dream支架系统能够更加精准地控制药物释放剂量，在保证疗效的同时显著降低进入人体的总药物负荷。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","09997","09996","02172","BK4588","BK1574","BK1222","BK4585","LABU","BK1583","BK1100"],"gpt_icon":0},{"id":"2620690233","title":"浩欧博(688656.SH)子公司获得2项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2620690233","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620690233?lang=zh_cn&edition=full","pubTime":"2026-03-18 16:03","pubTimestamp":1773821033,"startTime":"0","endTime":"0","summary":"浩欧博(688656.SH)发布公告，公司全资子公司湖南浩欧博生物医药有限公司于近日获得2项由湖南省药品监督管理局核准签发的医疗器械注册证，涉及产品：“抗丙氨酰tRNA合成酶(PL-12)抗体检测试剂盒(磁微粒化学发光法)”、“抗苏氨酰tRNA合成酶(PL-7)抗体检测试剂盒(磁微粒化学发光法)”。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/2.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/2.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","159883","09997","BK1222","688656","BK1100","09996","BK1574","BK0239"],"gpt_icon":0},{"id":"2620924423","title":"沛嘉医疗-B(09996)：DCwire® 微导丝获FDA 510(k)许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2620924423","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620924423?lang=zh_cn&edition=full","pubTime":"2026-03-17 18:15","pubTimestamp":1773742529,"startTime":"0","endTime":"0","summary":"智通财经APP讯，沛嘉医疗-B(09996)发布公告，由本公司附属公司加奇生物有限公司独立设计及开发的DCwire®微导丝近期已获得美国食品药品监督管理局的510(k)许可。这是本集团首个获得FDA许可的产品，也是本集团全球化战略的重要里程碑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","159891","BK1583","BK1100","BK1574","BK4588","09996","LABU"],"gpt_icon":0},{"id":"2620441471","title":"万东医疗(600055.SH)：“磁共振成像系统”取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2620441471","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620441471?lang=zh_cn&edition=full","pubTime":"2026-03-17 15:49","pubTimestamp":1773733771,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万东医疗(600055.SH)发布公告，公司于近日收到国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》，涉及产品：“磁共振成像系统”。上述注册证的取得，有助于进一步丰富公司产品结构，不断满足市场需求，有利于进一步增强公司的核心竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK0251","BK1100","BK0146","09997","BK0070","BK1583","BK0114","BK1574","09996","BK1222","600055"],"gpt_icon":0},{"id":"2619045006","title":"贝康医疗-B(02170)：PGT-A试剂盒获国家药监局颁发医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619045006","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619045006?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:05","pubTimestamp":1773662722,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 公布，公司基于国产高通量基因测序平台的 PGT-A试剂盒，胚胎植入前染色体非整倍体检测试剂盒，于2026年3月13日成功获批国家三类医疗器械注册证，成为全国首个基于纯国产自主平台测序仪的PGT-A试剂盒。PGT-A试剂盒透过筛检胚胎染色体非整倍体异常，能有效降低流产风险和出生缺陷发生率，是第三代试管婴儿技术的关键支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02170","BK1222","BK1583","BK1100","BK1574","159883","BK1597","09996","09997"],"gpt_icon":0},{"id":"2619454682","title":"昊海生物科技(06826)：眼内用交联透明质酸钠凝胶产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619454682","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619454682?lang=zh_cn&edition=full","pubTime":"2026-03-16 18:36","pubTimestamp":1773657416,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，上海昊海生物科技股份有限公司(以下简称“公司”)全资子公司上海其胜生物制剂有限公司(以下简称“其胜生物”)于近日收到国家药品监督管理局颁发的关于眼内用交联透明质酸钠凝胶产品(以下简称“本产品”)的《中华人民共和国医疗器械注册证》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1222","09996","BK1593","BK1161","BK1574","06826","BK1100","BK1583","159883"],"gpt_icon":0},{"id":"2619433584","title":"港股异动 | 京东健康(06618)涨超4% 与鱼跃医疗深化AI医疗器械战略合作 将聚焦血糖管理与呼吸健康领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2619433584","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619433584?lang=zh_cn&edition=full","pubTime":"2026-03-16 11:26","pubTimestamp":1773631606,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，京东健康涨超4%，截至发稿，涨4.39%，报51.15港元，成交额1.59亿港元。消息面上，据京东健康黑板报消息，近日，京东健康与国内领先的医疗器械品牌鱼跃医疗宣布达成全面战略合作。此次合作，双方致力于以AI重塑医疗器械、以技术驱动产品升级、以生态重构健康体验，依托京东健康在AI技术、数字化服务、全域供应链与用户运营等方面的核心能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK1222","159883","002223","BK4588","BK1247","BK1515","BK0251","BK0146","06618","BK4585","BK1589","LU0456827905.SGD","09997","09996","86618","BK1571","BK0185","BK0188","BK1100","SGXZ86797644.SGD","SGXZ62798434.SGD","BK0197","BK1574","BK1591","VXUS","BK1142","BK0114","BK1615","LU0051755006.USD","BK1583"],"gpt_icon":0},{"id":"2619487561","title":"国信证券：家用医疗器械赛道长期增长空间稳健 建议关注相关领域优质标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2619487561","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619487561?lang=zh_cn&edition=full","pubTime":"2026-03-16 09:35","pubTimestamp":1773624928,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国信证券发布研报称，家用医疗器械赛道长坡厚雪，中短期部分大单品展现强势结构性增长。在老龄化加深、居民健康管理意识增强以及技术和产品迭代等因素的驱动下，家用医疗器械赛道长期增长空间稳健。国信证券主要观点如下：家用医疗器械行业是银发经济下的高增长潜力赛道家用医疗器械是实现提升居民自我健康管理以及疾病早期干预能力的重要工具，广泛覆盖居家健康监测、呼吸治疗、康复医疗以及护理防护等领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002736","BK1583","BK0183","BK1100","159883","09996","BK0188","BK1574","09997","BK0028","BK1222","BK0276"],"gpt_icon":0},{"id":"2619481708","title":"首款侵入式脑机接口医疗器械获批；“增肌神药”黑产链被曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2619481708","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619481708?lang=zh_cn&edition=full","pubTime":"2026-03-16 08:15","pubTimestamp":1773620155,"startTime":"0","endTime":"0","summary":"政策动向“十五五”规划纲要发布，医疗领域顶层规划明晰3月13日，《中华人民共和国国民经济和社会发展第十五个五年规划纲要》正式发布。在第十一篇第三十九章“加快建设健康中国”中，提出实施健康优先发展战略。章节要点包括：健全公共卫生体系、建设优质高效医疗服务体系、健全医疗医保医药协同发展和治理机制、推进中医药传承创新、加快建设体育强国等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603163672553284.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603163672553284.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159883","BK1222","09996","BK1583","BK1574","09997","BK1100"],"gpt_icon":0},{"id":"2619101100","title":"315曝光“外泌体”乱象：涉事企业丽赛药业曾被罚没22万元，公司全国服务热线无人接听","url":"https://stock-news.laohu8.com/highlight/detail?id=2619101100","media":"新浪财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619101100?lang=zh_cn&edition=full","pubTime":"2026-03-15 21:58","pubTimestamp":1773583080,"startTime":"0","endTime":"0","summary":"　　3月15日晚间消息，央视315晚会曝光“万能”的外泌体问题，湖南丽赛药业有限公司被点名。行政处罚信息显示，2025年6月，该公司因违反了《医疗器械监督管理条例》相关规定，被湖南省药品监督管理局罚没合计22万余元。　　《BUG》栏目拨打了湖南丽赛药业有限公司全国服务热线，但无人接听。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/china/2026-03-15/doc-inhrascp9392885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1574","N0Z.SI","BK6096","BK1222","09997","BK1583","09996","BK6505"],"gpt_icon":0},{"id":"2619639197","title":"爱朋医疗：麻醉深度监护仪获3张三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619639197","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619639197?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:48","pubTimestamp":1773406108,"startTime":"0","endTime":"0","summary":"麻醉深度监护仪产品目前已获得3张三类医疗器械注册证；多模态ADHD行为治疗系统中脑电采集头环产品包括院内款和家用款，为二类医疗器械注册证；顽固性失眠麻醉治疗系统中的产品均拥有医疗器械注册证。公司暂未有命名为“脑机接口”名称的注册证。公司将积极研究国家和地区相关脑机接口利好政策，抓住政策机遇，推动公司业务发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300038215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK1574","09996","BK0251","BK1222","300753","BK1583","09997","159883"],"gpt_icon":0},{"id":"2619953561","title":"新产业最新公告：获得抗锌转运蛋白8抗体测定试剂盒医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619953561","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619953561?lang=zh_cn&edition=full","pubTime":"2026-03-13 18:10","pubTimestamp":1773396628,"startTime":"0","endTime":"0","summary":"新产业公告称，公司收到广东省药品监督管理局颁发的1项《医疗器械注册证》，产品名称为抗锌转运蛋白8抗体测定试剂盒，注册分类为Ⅱ类，注册证编号为粤械注准20262400269，有效期至2031年3月10日。该试剂盒用于体外定量测定人血清或血浆中锌转运蛋白8抗体的含量，临床上用于Ⅰ型糖尿病的辅助诊断。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300032673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","09997","09996","BK1222","BK1100","BK0239","BK1574","BK1583","300832"],"gpt_icon":0},{"id":"2619852193","title":"心脉医疗(688016.SH)：可解脱带纤维毛栓塞弹簧圈获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619852193","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619852193?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:48","pubTimestamp":1773395289,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心脉医疗(688016.SH)发布公告，近日，公司控股子公司上海鸿脉医疗科技有限公司获得国家药品监督管理局颁发的关于可解脱带纤维毛栓塞弹簧圈的医疗器械注册证。HawkMaster™/龙鸢™可解脱带纤维毛栓塞弹簧圈是公司继HawkNest™/鹰巢™带纤维毛栓塞弹簧圈之后获批上市的第二款弹簧圈栓塞类产品。该产品的上市进一步丰富了公司在外周动脉领域的产品组合，也进一步完善了公司在外周血管介入治疗领域的产品布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1574","159883","BK1222","688016","BK1583","BK0251","09996","BK1100"],"gpt_icon":0},{"id":"2619162946","title":"迈得医疗(688310.SH)控股子公司取得国内医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619162946","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619162946?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:26","pubTimestamp":1773390411,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈得医疗(688310.SH)发布公告，公司控股子公司迈得顺主要从事隐形眼镜研发、生产、销售，于近日取得经国家药品监督管理局审批的《中华人民共和国医疗器械注册证》，产品名称：软性亲水接触镜。上述产品医疗器械注册证的取得，有利于拓展公司业务范围，丰富公司产品品类，优化公司业务布局，促进公司长远战略规划逐步落地，并进一步提升公司综合竞争力，对公司的持续发展有积极促进作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1222","BK0251","BK1583","BK1574","BK1100","09997","159883","688310"],"gpt_icon":0},{"id":"2619477163","title":"国家药监局：首款侵入式脑机接口医疗器械获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2619477163","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619477163?lang=zh_cn&edition=full","pubTime":"2026-03-13 14:06","pubTimestamp":1773381998,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据央视报道，近日，国家药监局批准了博睿康医疗科技（上海）有限公司植入式脑机接口手部运动功能代偿系统创新产品注册申请，实现脑机接口医疗器械全球首发上市，标志着国际首个侵入式脑机接口医疗器械进入临床应用阶段。该产品采用硬脑膜外微创植入与无线供能通信技术，临床试验结果显示，受试者通过该产品实现了手部抓握能力的明显提高，进而改善患者生活质量。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/ODE3MzYxNTg1NDgwMzI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODE3MzYxNTg1NDgwMzI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"75e4c1a15c48c790c3f24275fd282084","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976450","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09997","BK1574","BK1100","BK1583","159883","BK1222","09996"],"gpt_icon":0},{"id":"2619150202","title":"单价跌破15万、心脏瓣膜价格雪崩蔓延：谁在离场，谁在重塑？","url":"https://stock-news.laohu8.com/highlight/detail?id=2619150202","media":"MedTrend医趋势","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619150202?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:19","pubTimestamp":1773317976,"startTime":"0","endTime":"0","summary":"3月11日，辽宁省挂网公布沛嘉医疗旗下三款经导管主动脉瓣系统价格，统一调整为15.99万元。尽管甘肃牵头的心脏瓣膜省际集采靴子尚未正式落地，但市场的降价潮已如海啸般席卷全国。01心脏瓣膜降价始末曾几何时，TAVR在中国的价格体系维持着一种微妙且昂贵的均衡。3月11日辽宁公布的沛嘉医疗主动降价至159,900元，实际上就是制度倒逼下的主动防御。目前，这场集采虽然尚在酝酿，但市场降幅却已提前透支。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031220291697af7533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031220291697af7533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09996","BK1100","BK1583"],"gpt_icon":0},{"id":"2619216150","title":"每日卖空追踪 | 沛嘉医疗-B 03月12日卖空量成交9000股，卖空比例为2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619216150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619216150?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304244,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间03月12日，跌1.37%，卖空量成交9000股，较上一交易日减少68.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163646a4637716&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163646a4637716&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","09996","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":0.0189},{"period":"1month","weight":-0.031},{"period":"3month","weight":0.0206},{"period":"6month","weight":-0.0931},{"period":"1year","weight":0.1833},{"period":"ytd","weight":-0.0116}],"compareEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":-0.0255},{"period":"3month","weight":0.0207},{"period":"6month","weight":-0.0196},{"period":"1year","weight":0.0519},{"period":"ytd","weight":0.0154}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057115},{"month":2,"riseRate":0.5,"avgChangeRate":0.017515},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.093756},{"month":4,"riseRate":0.75,"avgChangeRate":0.044776},{"month":5,"riseRate":0.75,"avgChangeRate":-0.061692},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07739},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}